318 related articles for article (PubMed ID: 8946662)
1. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Rambeck B; May T; Juergens U
Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
[TBL] [Abstract][Full Text] [Related]
5. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
Liu H; Delgado MR
Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448
[TBL] [Abstract][Full Text] [Related]
6. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Minkova GD; Getova DP
Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
[TBL] [Abstract][Full Text] [Related]
7. Relative proportions of serum carbamazepine and its pharmacologically active 10,11-epoxy derivative: effect of polytherapy and renal insufficiency.
Tutor-Crespo MJ; Hermida J; Tutor JC
Ups J Med Sci; 2008; 113(2):171-80. PubMed ID: 18509811
[TBL] [Abstract][Full Text] [Related]
8. Influence of additional therapy with zonisamide (Excegran) on protein binding and metabolism of carbamazepine.
Minami T; Ieiri I; Ohtsubo K; Hirakawa Y; Ueda K; Higuchi S; Aoyama T
Epilepsia; 1994; 35(5):1023-5. PubMed ID: 7925145
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
10. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
11. Developmental and therapeutic pharmacology of antiepileptic drugs.
Miura H
Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
[TBL] [Abstract][Full Text] [Related]
13. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
14. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR
Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
[TBL] [Abstract][Full Text] [Related]
15. Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children.
Tran A; Vauzelle-Kervroedan F; Rey E; Pous G; d'Athis P; Chiron C; Dulac O; Renard F; Olive G
Eur J Clin Pharmacol; 1996; 50(6):497-500. PubMed ID: 8858278
[TBL] [Abstract][Full Text] [Related]
16. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
Macphee GJ; Butler E; Brodie MJ
Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
[TBL] [Abstract][Full Text] [Related]
17. The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.
Muñoz JJ; De Salamanca RE; Diaz-Obregón C; Timoneda FL
Br J Clin Pharmacol; 1990 Jun; 29(6):763-5. PubMed ID: 2378792
[TBL] [Abstract][Full Text] [Related]
18. Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
Liu H; Delgado MR
Ther Drug Monit; 1994 Oct; 16(5):469-76. PubMed ID: 7846744
[TBL] [Abstract][Full Text] [Related]
19. Protein binding of carbamazepine and its epoxide in maternal and fetal plasma at delivery: comparison to other anticonvulsants.
Kuhnz W; Steldinger R; Nau H
Dev Pharmacol Ther; 1984; 7(1):61-72. PubMed ID: 6697871
[TBL] [Abstract][Full Text] [Related]
20. Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.
Zhu X; Yun W; Sun X; Qiu F; Zhao L; Guo Y
Pharmacogenomics; 2014; 15(15):1867-79. PubMed ID: 25495409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
